NCT01373398View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 29, 2012

Conditions
Bladder Cancer
Interventions
DRUG

EO9(Apaziquone)

immediate instillation after TURBT + 6 weekly instillation 4mg/mL Apaziquone

Trial Locations (2)

Unknown

Site 01, Seoul

Site 02, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY

NCT01373398 - Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) | Biotech Hunter | Biotech Hunter